Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Aeterna Zentaris Surprises Again
Motley Fool
Saturday, November 12, 2011 - 12:24pm
tags:
Aeterna Zentaris, Cetrotide, perifosine
Aastrom Biosciences to Hold Research and Development Day Review for Investors on November 17, 2011
Yahoo/GlobeNewswire
Saturday, November 12, 2011 - 12:23pm
tags:
Aastrom Biosciences, ixmyelocel-T
1 Reason the Street Should Expect Big Things From Sequenom
Motley Fool
Saturday, November 12, 2011 - 12:21pm
tags:
Sequenom
Amgen To Trade Ex-Dividend
Forbes
Saturday, November 12, 2011 - 12:19pm
tags:
Amgen
Affymax and Takeda Report Additional Analyses of Peginesatide Phase 3 Studies in Dialysis Patients at the American Society of Nephrology’s Kidney Week 2011
Yahoo/BusinessWire
Saturday, November 12, 2011 - 12:16pm
tags:
peginesatide, chronic kidney disease, dialysis, Affymax, Takeda
FDA, EMA accept Astellas bladder drug for review
Pharma Times, UK
Friday, November 11, 2011 - 1:04pm
tags:
FDA, EMA, overactive bladder, Astellas, mirabegron
FTC Commissioners Spar Over Pay-To-Delay Deals
Pharmalot
Friday, November 11, 2011 - 1:02pm
tags:
FTC, pay-for-delay
J&J Seeds an Ambitious Open R&D Program for Neuroscience
Motley Fool
Friday, November 11, 2011 - 12:45pm
tags:
JNJ, R&D, Neurosciences
5-Star Stocks Poised to Pop: Abbott Labs
Motley Fool
Friday, November 11, 2011 - 12:06pm
tags:
Abbott Laboratories
With IPO pending, Verastem raises $20M
Bizjournals.com
Friday, November 11, 2011 - 12:03pm
tags:
Verastem, IPO
Savient falls after analyst downgrades stock, expecting lower sales of its gout drug Krystexxa
Yahoo/AP
Friday, November 11, 2011 - 9:50am
tags:
Savient, gout, Krystexxa
FDA Turns Down Merck Birth Control Pill, Glaucoma Drug
Med Page Today
Friday, November 11, 2011 - 9:49am
tags:
FDA, Merck, glaucoma, birth control pill, tafluprost, Zoely
Merck's Latest Subpoena Reveals A Major Problem With The Pharmaceutical Industry
Yahoo/Business Insider
Friday, November 11, 2011 - 9:48am
tags:
Merck, subpoena
Drugmakers Lundbeck, Otsuka form global alliance
Reuters
Friday, November 11, 2011 - 9:46am
tags:
Otsuka, Lundbeck, aripiprazole depot, OPC-34712
New Sanofi/Regeneron Drug Leads To Dramatic Reductions In Bad Cholesterol
Forbes
Thursday, November 10, 2011 - 1:45pm
tags:
Sanofi, Regeneron, RGN727, LDL cholesterol, Lipitor
CSL May Win Australian Support to Widen Gardasil Vaccine Use
Bloomberg
Thursday, November 10, 2011 - 1:36pm
tags:
CSL, Australia, Gardasil, vaccines, HPV
The 3 Keys to Merck's Returns
Motley Fool
Thursday, November 10, 2011 - 1:35pm
tags:
Merck
Amylin target of renewed M&A murmurs
The Deal
Thursday, November 10, 2011 - 1:23pm
tags:
Amylin, M&A, Eli Lilly, Pfizer, Sanofi, GSK, Novo Nordisk
FDA: TriLipix may not cut patients' heart risks
Fierce Pharma
Thursday, November 10, 2011 - 1:21pm
tags:
FDA, TriLipix, fibrates, Abbott Laboratories
Justice subpoenas Merck on drug marketing
Fierce Pharma
Thursday, November 10, 2011 - 1:19pm
tags:
Merck, subpoena, Integrilin, Avelox, Azasite

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.